BlackRock Fund Advisors - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 45 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$185,000
+17.8%
33,080
+17.2%
0.00%
Q3 2016$157,000
-20.7%
28,229
-0.2%
0.00%
Q2 2016$198,000
+21.5%
28,292
+14.8%
0.00%
Q1 2016$163,000
-40.5%
24,653
-7.3%
0.00%
Q4 2015$274,000
-8.4%
26,585
+4.8%
0.00%
Q3 2015$299,000
+25.6%
25,363
-2.6%
0.00%
Q2 2015$238,00026,0350.00%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,132$1,821,0001.25%
Stonepine Capital Management, LLC 173,967$966,0000.79%
Krensavage Asset Management, LLC 288,294$1,600,0000.58%
ALGERT GLOBAL LLC 79,745$443,0000.13%
HEARTLAND ADVISORS INC 400,000$2,220,0000.13%
PERRITT CAPITAL MANAGEMENT INC 27,950$155,0000.04%
Spark Investment Management LLC 48,400$268,0000.02%
TFS CAPITAL LLC 14,707$82,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$1,000,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 36,210$201,0000.01%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders